Raymond James downgraded Press Ganey (NYSE:PGND) from Outperform to Mkt Perform in a report released today.
- Updated: September 20, 2016
Yesterday Press Ganey (NYSE:PGND) traded 0.22% lower at $40.23. PGND’s 50-day moving average is $40.38 and its two hundred day moving average is $35.19. With the last stock price up 14.31% from the 200-day average, compared with the S&P 500 Index which has fallen -0.01% over the date range. Volume of trade was was up over the average, with 1,070,835 shares of PGND changing hands over the typical 379,159 shares..
Raymond James has downgraded Press Ganey(NYSE:PGND) from Outperform to Mkt Perform in a report released 9/20/2016.
See Graphic Below:
A total of 9 brokerages have released a research note on the stock. Zero rate the company a strong buy, 0 rate the company a buy, 0 analysts rate the stock a hold, 0 rate the stock to underperform, and lastly 0 analystsrate the company as sell with an average target stock price of $37.56
Press Ganey has a 52 week low of $23.68 and a one-year high of $42.09 with a price-earnings ratio of 79. The company’s total market value is currently $0.0.
More About Press Ganey (NYSE:PGND)
Press Ganey Holdings, Inc. is a provider of patient experience and caregiver measurement, performance analytics and strategic advisory solutions for healthcare organizations. The Company provides its clients with a digital platform that captures the perspectives of patients, physicians, nurses and other healthcare employees and enables its clients to benchmark, analyze and manage the patient and caregiver experience. Its solutions include Patient Experience Solutions, which include Patient experience measurement, insights and advisory services; Caregiver Engagement Solutions, which include Physician, nurse and employee engagement measurement, insights and advisory services; Clinical and Quality Solutions, which include nursing quality indicators, patient reported outcome measures, core measures and eMeasures, and Consulting Solutions, which include patient safety and care reliability, patient experience improvement, process flow, and advanced analytics and insights and cultural alignment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.